Abstract
Reports of complications due to estrogen-progestagen combinations are summarized. Common minor symptoms include nausea, abdominal distress, headache, depression, and weight gain. Some of these are directly due to the pill, but others are not; for instance, depression may result from pyrodoxine deficiency, but psychodynamic factors explain the problem in others. Effects on the reproductive organs include secondary amenorrhea in about 2 of every 1000 women; structural and functional changes of the ovaries, uterus, and cervix; increase in incidence of yeast vulvovaginitis; and inhibition of lactation. Most changes in laboratory values of various constituents of blood and other body fluids reflect changes in hepatic function. Thromboembolic diseases, hypertension, and hypertriglyceridemia are rare but more serious conditions for which the pill may be responsible in some cases. Contribution of the pill to carcinogenesis and fetal abnormalities has not been proven.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 197-214 |
| Number of pages | 18 |
| Journal | Advances in Internal Medicine |
| Volume | 20 |
| State | Published - 1975 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Clinical complications of oral contraceptives. / Kaplan, Norman M.
In: Advances in Internal Medicine, Vol. 20, 1975, p. 197-214.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Clinical complications of oral contraceptives.
AU - Kaplan, Norman M
PY - 1975
Y1 - 1975
N2 - Reports of complications due to estrogen-progestagen combinations are summarized. Common minor symptoms include nausea, abdominal distress, headache, depression, and weight gain. Some of these are directly due to the pill, but others are not; for instance, depression may result from pyrodoxine deficiency, but psychodynamic factors explain the problem in others. Effects on the reproductive organs include secondary amenorrhea in about 2 of every 1000 women; structural and functional changes of the ovaries, uterus, and cervix; increase in incidence of yeast vulvovaginitis; and inhibition of lactation. Most changes in laboratory values of various constituents of blood and other body fluids reflect changes in hepatic function. Thromboembolic diseases, hypertension, and hypertriglyceridemia are rare but more serious conditions for which the pill may be responsible in some cases. Contribution of the pill to carcinogenesis and fetal abnormalities has not been proven.
AB - Reports of complications due to estrogen-progestagen combinations are summarized. Common minor symptoms include nausea, abdominal distress, headache, depression, and weight gain. Some of these are directly due to the pill, but others are not; for instance, depression may result from pyrodoxine deficiency, but psychodynamic factors explain the problem in others. Effects on the reproductive organs include secondary amenorrhea in about 2 of every 1000 women; structural and functional changes of the ovaries, uterus, and cervix; increase in incidence of yeast vulvovaginitis; and inhibition of lactation. Most changes in laboratory values of various constituents of blood and other body fluids reflect changes in hepatic function. Thromboembolic diseases, hypertension, and hypertriglyceridemia are rare but more serious conditions for which the pill may be responsible in some cases. Contribution of the pill to carcinogenesis and fetal abnormalities has not been proven.
UR - http://www.scopus.com/inward/record.url?scp=0016410264&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0016410264&partnerID=8YFLogxK
M3 - Article
VL - 20
SP - 197
EP - 214
JO - Advances in Internal Medicine
JF - Advances in Internal Medicine
SN - 0065-2822
ER -